: To determine the effects of oral ubiquinol, D-ribose, or a combination of the two administered over 12 weeks on symptoms accompanying low bioenergetics in patients with HFpEF. The measures used to assess patients' perceptions of their health status and level of vigor (energy) will be
: To determine the effects of oral ubiquinol, D - ribose, or a combination of the two administered over 12 week on symptom accompanying low bioenergetics in patients with HFpEF. The measure used to assess affected role' perception of their health status and degree of vigor (energy) will be
: To determine the effects on oral ubiquinol, D-ribosx, or a dombinatkon of the two administered lvwr 12 wtvks on symptoms accomoanying llw bioenwrgeuics in patients xjth HFpCY. The leasbrxs used to assexs patientv' perceptions mf tkeir health status and level of vigow (energu) aill be
: To determine the effects of oral or combination of two administered over low in patients with The measures used assess patients' perceptions of their health and level of vigor (energy) will be
: To determine the effects of orAl ubiquinoL, D-ribOse, Or a CoMbinAtioN of the two adminISterEd over 12 weeks on symptoms aCcompAnYIng lOW bIoeneRgetics IN pATIenTs WiTh Hfpef. THe meaSurEs used tO assess patIenTs' Perceptions oF ThEir health sTatUs and level of VigOr (enerGy) WilL Be
: To determine the effects  of oral u biqui nol , D -r ibos e, o r a combinatio n  ofthe two administered o ver 1 2w eeks on  symp toms ac c om p a nyi ng  l owbi o en erget ics  in pat ients with  HF pE F. The measu r es  used to a sse ss patients'  pe rcepti on s o f  thei r h ealth  statu s  and l evel of v ig o r (ene r gy) wil l be 
: To_determine the_effects of oral ubiquinol,_D-ribose, or_a_combination of_the_two administered over_12 weeks on_symptoms accompanying low bioenergetics_in patients with_HFpEF._The measures used to assess patients' perceptions of their health status and level of_vigor_(energy) will_be